(Q95401909)
Statements
Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus (English)
Kazuaki Chayama
Michio Imamura
Hiroshi Aikata
Masataka Tsuge
Tomokazu Kawaoka
Yoshiiku Kawakami
Akira Hiramatsu
Hidenori Ochi
Hideyuki Hyogo
Hatsue Fujino
Hiromi Kan
Takayuki Fukuhara
Noriaki Naeshiro
Yohji Honda